Posted by Michael Wonder on 23 Mar 2023
Cidara Therapeutics and Melinta Therapeutics announce FDA approval of Rezzayo (rezafungin for injection) for the treatment of candidemia and invasive candidiasis
22 March 2023 - Rezzayo is the first new FDA approved echinocandin in over a decade.
Cidara Therapeutics and Melinta Therapeutics today announced that the US FDA approved Rezzayo (rezafungin for injection) for the treatment of candidaemia and invasive candidiasis in adults with limited or no alternative treatment options.
